Company profile: Agensys
1.1 - Company Overview
Company description
- Provider of therapeutic human monoclonal antibodies and antibody drug conjugates for cancer treatment, engaging in research and development and offering products to treat various tumors, including prostate, pancreatic, and bladder cancers.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Agensys
Elevation Oncology
HQ: United States
Website
- Description: Provider of precision medicines as a clinical-stage biopharmaceutical company, developing EO-3021, an antibody-drug conjugate targeting Claudin 18.2 for advanced/metastatic solid tumors, particularly gastric and gastroesophageal junction adenocarcinoma, and Seribantumab, an anti-HER3 monoclonal antibody for NRG1 fusion-positive tumors; conducts clinical trials and offers compassionate use.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Elevation Oncology company profile →
Angle
HQ: United Kingdom
Website
- Description: Provider of liquid biopsy cancer diagnostic products for the capture and harvest of circulating tumor cells.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Angle company profile →
Spirogen
HQ: United Kingdom
Website
- Description: Provider of novel, sequence-selective DNA minor groove-binding molecules and proprietary pyrrolobenzodiazepine (PBD) technology, including PBD-based ADC payloads and PBD dimers that cross-link DNA to block replication and kill cancer stem cells. Offers licensing of PBD technology and research collaborations/partnerships to develop PBD-based ADCs designed to deliver potent anticancer agents to cancer cells for different cancer treatments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Spirogen company profile →
Predilife
HQ: France
Website
- Description: Provider of predictive medicine solutions that combine proven medical techniques (genetic testing, medical imaging) with mathematical models and extensive statistical data to assess individual risk profiles for serious diseases. Offers a breast cancer five-year risk assessment with personalized follow-up and recommendations, and multi-pathology assessments for major cancers and cardiovascular diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Predilife company profile →
Northern Biologics
HQ: Canada
Website
- Description: Provider of state-of-the-art antibody discovery targeting novel and challenging oncology and fibrosis targets, developing therapeutic antibody candidates derived from a phage display platform developed and refined by world-leading researchers at the University of Toronto.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Northern Biologics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Agensys
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Agensys
2.2 - Growth funds investing in similar companies to Agensys
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Agensys
4.2 - Public trading comparable groups for Agensys
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →